SuperInvestor Bulletin Blog | Talkmarkets | Page 1
Subscription Investment Newsletter
Contributor's Links: SuperInvestor Bulletin

Just because you can’t invest directly in the top hedge funds doesn’t mean that you can’t invest alongside them.

What we do here at Superinvestor Bulletin is track everything that the very best hedge fund managers are buying and selling.

And we don’t ... more


Latest Posts
1 to 8 of 8 Posts
E The Augmented Reality Market Is Expected To Increase At Least Tenfold By 2021
This sector is a tremendous opportunity, but I worry about the speed that technology is changing.
E They Have An App For Everything – Should You Invest In One That Steers You Away From Trouble?
Ten years ago I didn't know what an "app" was. Today a good one can be one of the highest margin businesses on the planet which is why I'm trying to learn about as many of them as I can.
Two Huge Warning Signs - The 8-Year Bull Market Birthday And The 10-Year Low VIX Reading
There are so many alarm bells ringing that a major market correction is near at hand that investors would be foolish not to pay attention.
Taking Marijuana In Another Direction – Kalytera Therapeutics
While everyone (including me) searches for a way to profit from the legalization of marijuana, Kalytera Therapeutics focuses on its medical benefits.
E Pershing Gold – Steady Insider Buying And A Catalyst For Revaluation
Pershing Gold gets into my pool of potential investments through insider buying. A discounted valuation and looming catalyst could explain sizable insider buying at Pershing Gold.
E Exploring The Regular Insider Buying At Biostage Inc.
Biostage’s share price experienced a decline back in May of this year. Since then, insider buying has been pretty steady and it has come from a variety of different insiders.
E VBI Vaccines – An Idea For Investors Who Want To Avoid The Index Fund Bubble
The current bull market is beyond long in the tooth but there are opportunities outside of index fund stocks. The biotech/pharma area of the market is one that could present opportunity.
E VBI Vaccines – The Leading Product In The Race For A $3 Billion Market
A recent merger adds some diversification and a strong shareholder base provides capital support for this small company that is worth watching. That said, there is risk.
1 to 8 of 8 Posts